| 发明名称 |
GALECTIN-3 AND CARDIAC RESYNCHRONIZATION THERAPY |
| 摘要 |
<p>The present invention relates to materials and methods for monitoring and predicting a heart failure patient's physiological response to cardiac resynchronization therapy. More specifically, the present invention relates to the endogenous protein galectin-3 and its use in monitoring progression of disease in a patient undergoing cardiac resynchronization therapy, and as a predictor of response to cardiac resynchronization therapy.</p> |
| 申请公布号 |
WO2011031493(A2) |
申请公布日期 |
2011.03.17 |
| 申请号 |
WO2010US46689 |
申请日期 |
2010.08.25 |
| 申请人 |
BG MEDICINE, INC.;MUNTENDAM, PIETER |
发明人 |
MUNTENDAM, PIETER |
| 分类号 |
G01N33/68;G01N33/15;G01N33/53 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
